跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 294,122 条关于
“hereditary ATTR with polyneuropathy”
全部
294,122
临床试验
251,760
药物
1,636
机构
405
资讯
40,321
去年
EU Approves WAINZUA (Eplontersen) for Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
2年前
FDA Approves AstraZeneca and Ionis' Wainua for Hereditary ATTR Polyneuropathy
2年前
Intellia Therapeutics Reports First Quarter 2024 Financial Results and Operational Progress
去年
Intellia's CRISPR Therapy Nexiguran Ziclumeran Shows Promise in ATTR Amyloidosis Phase 1 Trial
7个月前
Alnylam Pharmaceuticals Prepares for Q4 Results with Amvuttra Sales Surge and Pipeline Advances
去年
Intellia's NTLA-2001 Shows Promise in Early ATTR-CM Trial
去年
Intellia's CRISPR Therapy Nex-z Shows Promise in ATTR Amyloidosis Phase 1 Trial
去年
Intellia's Nexiguran Ziclumeran Shows Promising Phase 1 Results in ATTR Amyloidosis
去年
Intellia Therapeutics Prioritizes Late-Stage CRISPR Therapies, Announces Workforce Reduction
去年
Intellia's CRISPR Therapy Nexiguran Ziclumeran Shows Promise in ATTR Amyloidosis Phase 1 Trial
第 1 页,共 4033 页
上一页
下一页